Tvardi Therapeutics, Inc. 8-K

What Happened
On March 31, 2026, Tvardi Therapeutics, Inc. announced its financial results and business highlights for the fiscal quarter and year ended December 31, 2025 via a press release. The company furnished the press release under Item 2.02 (Results of Operations and Financial Condition) of an SEC Form 8-K; the release is attached as Exhibit 99.1 to the filing.

Key Details

• Press release dated March 31, 2026 announcing financial results for the quarter and year ended December 31, 2025 (Exhibit 99.1).
• Information furnished under Item 2.02 (Results of Operations and Financial Condition).
• Interactive XBRL cover page included as Exhibit 104 for machine-readable financial data.

Why It Matters
This 8-K signals that Tvardi has published its latest quarterly and full-year financial performance and any related business highlights — important for investors tracking earnings, revenue, guidance or program updates. Retail investors should read the attached press release (Exhibit 99.1) and the XBRL data to see the actual figures and any operational or forward-looking commentary the company provided.